{"id":"https://openalex.org/W4416075944","doi":"https://doi.org/10.1016/j.jid.2025.09.120","title":"102 Characterization of ORKA-002, a Novel Extended Half-life Monoclonal Antibody Targeting IL-17A/F for the Treatment of Psoriasis and Other Indications","display_name":"102 Characterization of ORKA-002, a Novel Extended Half-life Monoclonal Antibody Targeting IL-17A/F for the Treatment of Psoriasis and Other Indications","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4416075944","doi":"https://doi.org/10.1016/j.jid.2025.09.120"},"language":"en","primary_location":{"id":"doi:10.1016/j.jid.2025.09.120","doi":"https://doi.org/10.1016/j.jid.2025.09.120","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2025.09.120","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.jid.2025.09.120","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025127416","display_name":"Byron H. Kwan","orcid":"https://orcid.org/0000-0002-9851-7029","observed_orcids":["https://orcid.org/0000-0002-9851-7029"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Byron Kwan","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047076464","display_name":"Joseph Frank Merola","orcid":"https://orcid.org/0000-0001-6514-4353","observed_orcids":["https://orcid.org/0000-0001-6514-4353"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Merola","raw_affiliation_strings":["UT Southwestern Medical Center, Dallas, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center, Dallas, United States","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080237247","display_name":"Andrew Blauvelt","orcid":"https://orcid.org/0000-0002-2633-985X","observed_orcids":["https://orcid.org/0000-0002-2633-985X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Blauvelt","raw_affiliation_strings":["Blauvelt Consulting, LLC, Annapolis, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blauvelt Consulting, LLC, Annapolis, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel Rios","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Rios","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040117781","display_name":"Joana Ministro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joana Ministro","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079029701","display_name":"Jacob C. Milligan","orcid":"https://orcid.org/0000-0002-9369-0025","observed_orcids":["https://orcid.org/0000-0002-9369-0025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob Milligan","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033142616","display_name":"Ghassan N. Fayad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ghassan Fayad","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Finch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Finch","raw_affiliation_strings":["Oruka Therapeutics , Waltham, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oruka Therapeutics , Waltham, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038443826","display_name":"Eugenia Levi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugenia Levi","raw_affiliation_strings":["Oruka Therapeutics , Waltham, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oruka Therapeutics , Waltham, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035351445","display_name":"Joseph J. Senn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Senn","raw_affiliation_strings":["Oruka Therapeutics , Waltham, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oruka Therapeutics , Waltham, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102605150","display_name":"Jason Oh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Oh","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056524397","display_name":"Hussam Shaheen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hussam Shaheen","raw_affiliation_strings":["Paragon Therapeutics, Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paragon Therapeutics, Waltham, United States of America","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25167117,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"145","issue":"11","first_page":"e48","last_page":"e48"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-17a-f","display_name":"IL-17A/F","score":0.8220000267028809},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9089999794960022},{"id":"https://openalex.org/keywords/extended-half-life","display_name":"extended half-life","score":0.8510000109672546},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/il-17-receptor-antagonist","display_name":"IL-17 receptor antagonist","score":0.6169999837875366},{"id":"https://openalex.org/keywords/antibody-characterization","display_name":"antibody characterization","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8636999726295471},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.8069999814033508},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7753000259399414},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.45320001244544983},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37770000100135803},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.375},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3668000102043152},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.36419999599456787},{"id":"https://openalex.org/C2777843201","wikidata":"https://www.wikidata.org/wiki/Q17163357","display_name":"Monoclonal antibody therapy","level":4,"score":0.28790000081062317},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.21119999885559082}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jid.2025.09.120","doi":"https://doi.org/10.1016/j.jid.2025.09.120","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2025.09.120","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jid.2025.09.120","doi":"https://doi.org/10.1016/j.jid.2025.09.120","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2025.09.120","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413881830","https://openalex.org/W4412539988","https://openalex.org/W7167467017","https://openalex.org/W4411431405","https://openalex.org/W4416083762","https://openalex.org/W4408497943","https://openalex.org/W4416140817","https://openalex.org/W4416141064","https://openalex.org/W4405229378","https://openalex.org/W2736694669"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-10T00:00:00"}